Kentaro Muraoka

PD-1 and PD-L1 are more highly expressed in high-grade bladder cancer than in low-grade cases: PD-L1 might function as a mediator of stage progression in bladder cancer

Takashi Kawahara, Yukari Ishiguro, Shinji Ohtake et al. · BMC Urology · 2018 · 59 citations · Full text

Medicine, Oncology, Pathology +17

Early assessment with 18F-2-fluoro-2-deoxyglucose positron emission tomography/computed tomography to predict short-term outcome in clear cell renal carcinoma treated with nivolumab

Tadashi Tabei, Noboru Nakaigawa, Tomohiro Kaneta et al. · BMC Cancer · 2019 · 25 citations · Full text

Medicine, Oncology, Radiology +17

Outcomes of treatment for localized prostate cancer in a single institution: comparison of radical prostatectomy and radiation therapy by propensity score matching analysis

Narihiko Hayashi, Kimito Osaka, Kentaro Muraoka et al. · World Journal of Urology · 2019 · 24 citations

Medicine, Surgery, Urology +14

BHD-associated kidney cancer exhibits unique molecular characteristics and a wide variety of variants in chromatin remodeling genes

Hisashi Hasumi, Mitsuko Furuya, Kenji Tatsuno et al. · Human Molecular Genetics · 2018 · 23 citations · Full text

Medicine, Genetics, Oncology +17

Galectin-9 expression as a poor prognostic factor in patients with renal cell carcinoma

Ryosuke Jikuya, Takeshi Kishida, Masahiko Sakaguchi et al. · Cancer Immunology Immunotherapy · 2020 · 22 citations · Full text

Medicine, Cancer Biology, Oncology +11